Open AccessPirfenidone vs nintedanib for treatment of idiopathic pulmonary fibrosis in clinical practice: efficacy, tolerability, and adverse effects
Author(s) -
AmalA.E.-A Sadon,
Ahmed S. Kenawy,
AshrafH Abdelsalam,
HosamM Attia
Publication year - 2020
Publication title -
egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.4103/ejcdt.ejcdt_140_19
Subject(s) - nintedanib , pirfenidone , medicine , tolerability , idiopathic pulmonary fibrosis , vital capacity , adverse effect , gastroenterology , diffusing capacity , lung , lung function
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom